ZEPHYR ENDOBRONCHIAL VALVE: payments to doctors
Payments that named ZEPHYR ENDOBRONCHIAL VALVE as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $3.2M
- Providers
- 6,840
- Transactions
- 17,406
- Average per transaction
- $186
The per-transaction average — $186 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 6,840 providers the average total is $474, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Pulmonx Corporation | $3,242,169 | 100.0% |